MARKET

OBIO

OBIO

Orchestra BioMed Holdings Inc
NASDAQ
4.240
+0.340
+8.72%
After Hours: 4.178 -0.062 -1.46% 18:43 06/26 EDT
OPEN
3.900
PREV CLOSE
3.900
HIGH
4.310
LOW
3.900
VOLUME
5.42M
TURNOVER
--
52 WEEK HIGH
5.42
52 WEEK LOW
2.200
MARKET CAP
253.89M
P/E (TTM)
-3.7324
1D
5D
1M
3M
1Y
5Y
1D
Health Care had the best week vs. the S&P 500 on record
Seeking Alpha · 7h ago
Orchestra BioMed Shareholders Approve Directors and Incentive Plan
TipRanks · 3d ago
Orchestra BioMed shareholders approved 2026 annual meeting proposals
PUBT · 3d ago
Weekly Report: what happened at OBIO last week (0615-0619)?
Weekly Report · 4d ago
Orchestra BioMed Holdings (OBIO) Gets a Hold from BTIG
TipRanks · 06/18 01:08
Weekly Report: what happened at OBIO last week (0608-0612)?
Weekly Report · 06/15 09:23
Weekly Report: what happened at OBIO last week (0601-0605)?
Weekly Report · 06/08 09:22
Orchestra BioMed posts investor deck spotlighting pivotal-stage AVIM hypertension therapy and Virtue sirolimus balloon program
PUBT · 06/04 13:49
More
About OBIO
Orchestra BioMed Holdings, Inc. is a biomedical innovation company. The Company’s lead product candidates include Atrioventricular Interval Modulation (AVIM) therapy for the treatment of hypertension (HTN), the leading risk factor for death worldwide and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. The Company develops bioelectronic therapies based on patented Cardiac Neuromodulation Therapy (CNT) technology. The AVIM is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Its Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant.

Webull offers Orchestra Biomed Holdings Inc stock information, including NASDAQ: OBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OBIO stock methods without spending real money on the virtual paper trading platform.